Chronic Hepatitis D clinical trials

Explore recruiting chronic hepatitis d clinical trials.

Recruiting chronic hepatitis d studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hepatitis D trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants with Chronic Hepatitis D Virus Infection (SOLSTICE)

France, Romania, Netherlands, Germany, Bulgaria, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)

Germany, Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection

France, Austria, Germany, Romania, Belgium, Spain +1 more

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)

Czechia, Austria, Spain, Romania, Germany, Italy +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Austria, Italy, Czechia, Romania, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis D

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

Chronic Hepatitis D trials by city

Chronic Hepatitis D clinical trials

Recruiting chronic hepatitis d studies right now

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)